Notes
National Health Service
Reference
McKee S. NICE turns down Shire's Revestive for bowel condition Pharma Times : 14 Nov 2017. Available from: URL: http://www.pharmatimes.com/news/nice_turns_down_shires_revestive_for_bowel_condition_1211408
Rights and permissions
About this article
Cite this article
NICE not recommending teduglutide for SBS. PharmacoEcon Outcomes News 792, 34 (2017). https://doi.org/10.1007/s40274-017-4557-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4557-8